Stem Cells and Cancer Stem Cells,Volume 3

PREFACE. -1. Introduction. -2. Diversity oriented fluorescence library approach for stem cell probe development. -3. Isolation of mesenchymal stem cells from umbilical cord (method). -4. Mesenchymal stem cell isolation and expansion methodology. -5. Hair follicle stem cells. - 6. Rat embryonic cortical neural stem cells: role of hypoxia on cell proliferation and differentiation. -7. Human cord blood-derived hematopoietic stem and progenitor cells: from biology to medicine. -8. Proteomic characterization of mesenchymal stem cell-like populations derived from various tissue types. -9. The roles of nanog during early embryonic development and primordial germ cell migration. -10. Human embryonic stem cells in serum-free media: growth and metabolism. I. MOLECULAR GENETICS. -11. Evolutionary dynamics of mutations in hematopoietic stem cells and beyond. -12. Isolated corneal epithelial stem cells derived from limbal biopsies: use of lectin as a marker for identifying transient amplifying cells. -13. Stem cell distribution and mgmt expression in glioblastoma: role of intratumoral hypoxic gradient. - 14. Initiation of human tumourigenesis: upregulation of foxm1 transcription factor. II THERAPY. -15. Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy. -16. Ccell-based regenerative therapies: role of major histocompatibility complex-1 antigen. -17. Mesenchymal stem cells for cellular therapies. -18. Radiation burns and mesenchymal stem cell therapy. -19. Mesenchymal stem cells: role of mechanical strain in promoting apoptosis and differentiation. -20. Human mesenchymal stem cells: melatonin as a potential anti-osteoporosis drug. -21. Applications of human - induced pluripotent stem cell derived hepatocytes. -22. Stem cells and gastric carcinogenesis: from mouse to human. -23. Gain and loss of cancer stem cells: effect on metastatic efficiency and treatment response. -24. Treatment ofischemia/reperfusion injury of the kidney with mesenchymal stromal cells. -25. Mesenchymal stem cells: role for delivering nanoparticles to brain tumors. -26. Human induced pluripotent stem cells: role in patient specific drug discovery. -27. Biomedical applications of induced pluripotent stem cells. -28. Duchenne muscular dystrophy: isolation of cd133-expressing myogenic progenitors from blood and muscle of dmd patients. III TRANSPLANTATION. -29. Human fetal mesenchymal stem cells for prenatal and postnatal transplantation. -30. Protection of mice from stroke using hematopoietic stem cell transplantation. -31. Neonatel hypoxic-ischemic encephalopathy: neural stem/progenitor cell transplantation. IV TISSUE REGENERATION. -32. Mesenchymal stem cell-dependent formation and repair of tendon-done insertions. -33 . Cartilage injuries: role of implantation of human stem/progenitor cells. -34. Bone marrow-derived very small embryonic-like cells: ß-cell regeneration in pancreatic tissue. - 35. Engineering stem cell niche: regulation of cellular morphology and function. - V APOPTOSIS. -36. Embryonic stem cells: the role of nitric oxide in regulating cell differentiation, self-renewal, and apoptpsis. - 37. Induction of apoptosis in human keratinocyte stem cells: the role of hydrogen sulfide. Index